AstraZeneca doses set to arrive tomorrow — but questions remain about who gets them first
News/Politics: The first batch of Canada's supply of the AstraZeneca-Oxford vaccine is set to arrive tomorrow — but public health officials still have some rollout issues to sort out before they can deliver those shots.
Scientists find 'HIV elite controllers' living in Congo, possibly paving way for vaccine, cure
Scientists have claimed to discover a rare group of people in the Democratic Republic of Congo who have tested positive for HIV antibodies but are living with low to non-detectable levels of viral load without the aid of antiretroviral medicines, potentially paving the way for vaccine development or possibly even a cure.
Ontario sees 966 new COVID-19 cases as questions over vaccine timing linger
News/Canada/Toronto: Ontario reported another 966 cases of COVID-19 on Tuesday, as debate continues around whether the province should expand the time between vaccine doses to speed up its immunization efforts.
Adhere to Pfizer, Moderna two-dose COVID-19 vaccine regimen, Fauci says: report
National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony Fauci has reiterated that the U.S. will adhere to two-shot coronavirus vaccine regimens for products developed by Pfizer-BioNTech and Moderna, according to a report.
Essential workers should be prioritized for AstraZeneca vaccine, experts suggest
News: Essential workers who are more likely to contract and transmit COVID-19 should be prioritized for immunization with the Oxford-AstraZeneca vaccine now that a national panel is not recommending it for seniors, two experts say.
Why Canada's pandemic experience has been easier than some
News/Politics: Canada has fallen behind many of its wealthy nation peers in its efforts to vaccinate the population. But the efficiency of the vaccine rollout isn't the only measure of a country's pandemic experience — and according to other measures, Canada has fared relatively well.
CDC warns that all recent COVID-19 gains can be lost due to new variants
Dr. Rochelle Walensky, the head of the U.S. Centers for Disease Control and Prevention, said Monday that she is concerned about the virus’ variants and said the recent ground the country made in combating the disease could be lost.
WHO panel issues strong advice against hydroxychloroquine for COVID-19
News/World: The drug hydroxychloroquine, once touted by former U.S. president Donald Trump as a pandemic "game-changer," should not be used to prevent COVID-19 and has no meaningful effect on patients already infected, a World Health Organization expert panel said on Tuesday.
Canada's chief science adviser issues warning about B.C.'s 'experiment' with vaccine timing
News/Politics: British Columbia's decision to extend to four months the interval between first and second doses of three different vaccines amounts to a "population level experiment," said Mona Nemer, Canada's chief science adviser.
Oxford-AstraZeneca's COVID-19 vaccine not recommended for seniors, committee says
News/Health: The National Advisory Committee on Immunizations (NACI) has recommended against using the Oxford-AstraZeneca vaccine in people aged 65 and older, although Health Canada has authorized it to be used in adults of all ages.
Countries urge drug companies to share vaccine know-how
Across Africa and Southeast Asia, governments and aid groups, as well as the World Health Organization, are calling on pharmaceutical companies to share their patent information more broadly to meet a yawning global shortfall in a pandemic that already has claimed over 2.5 million lives.